$ZYME Cashflow Statement | Understand Stock

$ZYME

$28.37 +$0.15 (0.53%) Close

$ZYME Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Cash flows from operating activities:
Net loss
Items not involving cash:
Depreciation of property and equipment (note 7)
Amortization of intangible assets (note 8)
Stock-based compensation (note 10e)
Amortization and impairment of operating lease right-of-use assets
Impairment of acquired IPR&D (note 6)
Deferred income tax expense (recovery) (note 13)
Non-cash consideration from licensing agreement
Change in fair value of contingent consideration liability (note 15)
Change in fair value of investments in equity instruments
Unrealized foreign exchange loss (gain)

Changes in non-cash operating working capital:
Accounts receivable
Prepaid expenses and other current assets
Accounts payable and accrued liabilities
Operating lease liabilities
Deferred revenue and other consideration
Income taxes payable
Net cash used in operating activities
Cash flows from financing activities:
Proceeds from issuance of common stock under at-the-market program and from public offerings, net of issuance costs (notes 10a)
Private placement (note 10a)
Issuance of common stock on exercise of stock options (note 10e)
Issuance of common stock through employee stock purchase plan (note 10f)
Purchases of common stock for retirement (note 10c)
Deferred financing fees
Finance lease payments
Net cash (used in) / provided by financing activities
Cash flows from investing activities:
Net redemptions (purchases) of short-term investments
Purchases of long-term investments
Purchases of marketable securities
Proceeds from marketable securities
Acquisition of property and equipment
Acquisition of intangible assets
Net cash provided by / (used in) investing activities

Effect of exchange rate changes on cash and cash equivalents
Net change in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Supplemental cash flow information:
Net cash paid during the year for income taxes
Supplemental disclosure of non-cash investing and finance items:
Leased assets obtained in exchange for operating lease liabilities
Issuance of common stock upon exercise of pre-funded warrants (note 10d)
Purchases of common stock not settled
Acquisition of property and equipment and intangible assets in accounts payable and accrued liabilities

Comments